An evaluation of weight gain in patients treated with dolutegravir and other core agents (209025)

Study identification

• EU PAS number:
  EUPAS28753
• Study ID:
  42179
• Official title and acronym:
  An evaluation of weight gain in patients treated with dolutegravir and other core agents (209025)
• DARWIN EU® study:
  No
• Study countries:
  United States
• Study status:
  Finalised

Research institutions and networks

Institutions

ViiV Healthcare

Study timelines

Date when funding contract was signed

Planned: 17/07/2018

Actual: 17/07/2018

Study start date

Planned: 21/03/2019

Actual: 08/03/2019

Data analysis start date

Actual: 10/04/2019

Date of final study report

Planned: 31/01/2020

Actual: 30/01/2020

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

ViiV Healthcare

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable